Perioperative FLOT plus anti-PD-L1 avelumab (FLOT-A) in resectable oesophagogastric adenocarcinoma (OGA): Interim safety analysis results from the ICONIC trial.

Athauda, A; Starling, N; Chau, I; Cunningham, D; Watkins, DJ; Rao, S; Kalaitzaki, E; Bourmpaki, E; Davidson, M; Gillbanks, A; Lazaro-Alcausi, R; Moneypenny, M; Begum, R; von Loga, K; Rana, I; Patel, P; Doran, S; Kumar, S; Chaudry, A; Gerlinger, M

JOURNAL OF CLINICAL ONCOLOGY, 2021; 39 (3):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索